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Primary cilia are microtubule-based organelles that extend from the apical surface
of most mammalian cells, forming when the basal body (derived from the mother
centriole) docks at the apical cell membrane. They act as universal cellular “antennae”
in vertebrates that receive and integrate mechanical and chemical signals from the
extracellular environment, serving diverse roles in chemo-, mechano- and photo-
sensation that control developmental signaling, cell polarity and cell proliferation.
Mutations in ciliary genes cause a major group of inherited developmental disorders
called ciliopathies. There are very few preventative treatments or new therapeutic
interventions that modify disease progression or the long-term outlook of patients
with these conditions. Recent work has identified at least four distinct but interrelated
cellular processes that regulate cilia formation and maintenance, comprising the cell
cycle, cellular proteostasis, signaling pathways and structural influences of the actin
cytoskeleton. The actin cytoskeleton is composed of microfilaments that are formed
from filamentous (F) polymers of globular G-actin subunits. Actin filaments are organized
into bundles and networks, and are attached to the cell membrane, by diverse cross-
linking proteins. During cell migration, actin filament bundles form either radially at the
leading edge or as axial stress fibers. Early studies demonstrated that loss-of-function
mutations in ciliopathy genes increased stress fiber formation and impaired ciliogenesis
whereas pharmacological inhibition of actin polymerization promoted ciliogenesis. These
studies suggest that polymerization of the actin cytoskeleton, F-actin branching and the
formation of stress fibers all inhibit primary cilium formation, whereas depolymerization
or depletion of actin enhance ciliogenesis. Here, we review the mechanistic basis for
these effects on ciliogenesis, which comprise several cellular processes acting in concert
at different timescales. Actin polymerization is both a physical barrier to both cilia-
targeted vesicle transport and to the membrane remodeling required for ciliogenesis.
In contrast, actin may cause cilia loss by localizing disassembly factors at the ciliary
base, and F-actin branching may itself activate the YAP/TAZ pathway to promote cilia
disassembly. The fundamental role of actin polymerization in the control of ciliogenesis
may present potential new targets for disease-modifying therapeutic approaches in
treating ciliopathies.
Keywords: drug screen, ROCK inhibitors, ciliopathies, polycystic kidney disease, ciliogenesis, actin cytoskeleton,
cilia, cytoskeletal drugs
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INTRODUCTION
Primary cilia are microtubule-based organelles that extend from
the apical surface of the majority of mammalian cells (Figure 1).
Cilia act as “cellular antennae” in vertebrates, receiving diverse
inputs from the extracellular environment and transducing
signals in response. These signal inputs vary but include
mechanical stimuli, for example urine fluid shear stress in kidney
epithelial cells (Schwartz et al., 1997); proteins, such as those of
the Sonic Hedgehog (Shh) pathway (Huangfu et al., 2003); and
low molecular weight chemicals such as dopamine (Atkinson
et al., 2015). The specialized cilium of the photoreceptor, the
retinal outer segment, is also capable of sensing and transducing
signals in response to light (Molday and Moritz, 2015). Cilia
responses contribute to the control of developmental signaling
and cell proliferation, as well as the establishment of cell polarity
(Ross et al., 2005).
Mutations in ciliary genes cause a group of inherited
Mendelian developmental disorders termed ciliopathies.
Ciliopathies are individually rare but collectively common,
affecting up to 1 in 725 people (Wheway et al., 2019). These
heterogeneous conditions include kidney diseases, blinding
disorders, obesity associated diseases, severe neurodevelopmental
abnormalities and skeletal dysplasias [reviewed in Tobin and
Beales (2009) and Waters and Beales (2011)]. Ciliopathies can
result from defects in the organization or function of the main
ciliary components such as the basal body or transition zone,
or can be due to deficits in the trafficking of ciliary axoneme
components or the transcriptional regulation of ciliogenesis
(Reiter and Leroux, 2017).
Treatment options for ciliopathies have been limited to
date and have focused on alleviating symptoms rather than
treating the causes. Although antisense oligonucleotides, gene
replacement therapies and gene editing represent possible future
therapeutic avenues for ciliopathies, none are yet licensed (Kim
and Kim, 2019). Currently, only one drug is licensed for the
treatment of any ciliopathy, Tolvaptan, which has been shown
to slow the decline of renal function for patients with autosomal
dominant polycystic kidney disease (ADPKD) (Torres et al.,
2012, 2017). Tolvaptan is a selective vasopressin V2 receptor
antagonist, which ultimately decreases cAMP, reduces activation
of protein kinase A and decreases the number of aquaporin
channels in the collecting ducts of the kidney (Torres et al.,
2012, 2017). This increases water excretion and helps to reduce
cyst swelling, slowing decline in kidney function (Gattone et al.,
2003; Wang et al., 2008; Meijer et al., 2011; Torres et al., 2012).
Unfortunately, Tolvaptan is poorly tolerated due to its common
side effects, including polyuria, increased thirst, pollakiuria
and xerostomia (Gansevoort et al., 2016), as well as liver
damage that resolves upon discontinuation of the drug treatment
(Torres et al., 2012). Many other trials are ongoing, including
agents to reduce obesity in Bardet-Biedl syndrome and Alström
syndrome (NCT03746522) and neurotrophic (NCT00447993
and NCT0447980), anti-apoptotic drugs (Rossetti et al., 1990;
Piano et al., 2013; Byrne et al., 2016) and antioxidants (Dias
et al., 2018) to treat retinal diseases. Pharmacological agents (for
example, the cyclin-dependent kinase inhibitors (R)-roscovitine
or the derivative (S)-CR8) that shorten cilia have been tested
in animal models of ADPKD with some success (Husson et al.,
2016). In addition, many small molecule screens have highlighted
several promising compounds and target signaling pathways for
further testing (Khan et al., 2016; Booij et al., 2017; Kim et al.,
2018).
Understanding of cilia and ciliogenesis will be key to
formulating new treatments for ciliopathies. Cilia form cells in
G1 or G0 when the mother centriole docks at the apical cell
membrane to form the basal body. This event prompts the local
clearance of the layer of cortical actin bound to the plasma
membrane (Francis et al., 2011). Microtubules then nucleate
at the basal body to initiate the formation of the axoneme.
Ciliogenesis is therefore dependent on the cell cycle, is modified
by inputs from signaling pathways, but is also heavily influenced
by the actin cytoskeleton.
The actin cytoskeleton is composed of microfilaments that
are formed from filamentous (F) polymers of globular G-actin
subunits (Lodish et al., 2000; Figure 1, left inset). Actin filaments
are organized into bundles and networks that are attached to
the cell membrane by diverse cross-linking proteins. During cell
migration, actin filament bundles form either radially at the
leading edge or as axial stress fibers. Early studies demonstrated
that loss-of-function mutations in ciliopathy genes increased
stress fiber formation and impaired ciliogenesis (Dawe et al.,
2007; Valente et al., 2010) whereas pharmacological inhibition
of actin polymerization promoted ciliogenesis (Bershteyn et al.,
2010; Kim et al., 2010; Sharma et al., 2011). These studies
suggested that polymerization of the actin cytoskeleton, F-actin
branching and the formation of stress fibers all negatively
influence primary cilium formation, whereas depolymerization
or depletion of actin enhances ciliogenesis (Avasthi and
Marshall, 2012; Malicki and Johnson, 2017). Further support
that perturbation of the actin cytoskeleton affects ciliogenesis
came from a functional genomics screen to identify positive and
negative regulators of ciliogenesis (Kim et al., 2010).
Here we review the current understanding of how the actin
cytoskeleton influences ciliogenesis and cilia-dependent cellular
functions, such as the maintenance of apico-basal polarity,
and the mechanistic basis for these effects. We also discuss
the potential for the use of this knowledge to highlight new
targets for disease-modifying therapeutic approaches in treating
ciliopathies. We do not discuss the roles of signaling pathways
mediated by cilia that affect the actin cytoskeleton. Instead, we
direct the reader to another recent review which covers this topic
(Brücker et al., 2020).
THE ACTIN CYTOSKELETON
Actin was discovered in 1887, initially named “myosin
ferment” (Halliburton, 1887), it was then isolated from muscle
preparations in 1942 (Straub, 1942). It was not until the 1960s
that actin was detected in non-muscle cells (Hatano and Oosawa,
1966; Miki-Noumura and Oosawa, 1969). Actin is an abundant,
intracellular cytoskeletal protein that is ubiquitous in eukaryotic
cells. There are different isoforms, each encoded by one of six
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FIGURE 1 | The primary cilium, actin dynamics and the actin cytoskeleton. Main panel: The primary cilium and the actin cytoskeleton. The primary cilium forms when
the mother centriole docks at the apical membrane to form the basal body. Microtubules (gray cylinders) then nucleate at the basal body to initiate formation of the
axoneme with a 9+0 microtubule arrangement. The sub-distal appendages mediate microtubule anchoring, and the pericentriolar material may act as a microtubule
organizing center. Y-shaped links (dark brown) connect the microtubule doublets to the ciliary membrane at the ciliary transition zone, which acts as a gate to control
the entry and exit of proteins and lipids. Intraflagellar transport (IFT) protein complexes (orange and yellow) transport cargo (indicated by arrows) along the axoneme
by using microtubule based motor proteins. The ciliary pocket is an endocytic membrane domain around the base of the cilium implicated in actin dynamics, the
transport of membrane associated proteins to cilia and in ciliary disassembly. The ciliary tip is a source of extracellular vesicles and is involved in early ciliary
disassembly through decapitation. The actin cytoskeleton modulates ciliogenesis through effects on both vesicle trafficking (lower left; tan symbols and dashed
arrow) and actin cytoskeleton remodeling mediated by acto-myosin contractions (lower right; green symbols and arrows). Actin-binding proteins are indicated by
dark red symbols. Inset left: Microfilament assembly and treadmilling. Actin is present in cells as both a monomer (globular, G-actin) and a polymer (filamentous,
F-actin). Actin binds and can hydrolyze ATP to ADP. There is preferential additional of ATP-bound monomers to the (+) end of the polymer and ATP is hydrolyzed
upon filament assembly. The preferential dissociation of ADP-bound actin results in a “treadmilling” effect, whereby the F-actin filaments exhibit net growth at their (+)
ends and net dissociation at their (−) ends. Both polymerization and depolymerization require actin binding proteins. Profilin can sequester G-actin from the pool of
actin monomers but can also catalyze the exchange of ADP to ATP, converting monomers to the more polymerizable ATP-bound form. Actin polymerization requires
nucleating factors, such as Spire or formins, or the actin-related protein complex (ARP2/3). Actin depolymerization remains incompletely understood but members of
the yeast actin depolymerization factor (ADF)/cofilin family can enhance dissociation of monomers from the (−) end. Inset right: Actin cytoskeleton organization.
Many actin binding proteins can alter the arrangement and structure of F-actin. ARP2/3 can elicit F-actin branching. Members of the yeast actin depolymerization
factor (ADF)/cofilin family can both enhance dissociation of G-actin monomers from the (−) end and can sever filaments to produce additional (−) ends. Filamins and
various other actin binding proteins can crosslink actin to form complex networks, can anchor F-actin to membranes and can bundle actin into stress fibers.
genes in mammals [reviewed in Perrin and Ervasti (2010)]. Actin
also undergoes various post translational modifications that are
important to its functions [reviewed in Varland et al. (2019)].
It can be present as a free monomer, namely globular actin
(G-actin), or polymerized into linear filamentous actin (F-actin)
(Straub, 1943). F-actin is a major component of the cytoskeleton,
a dynamic network that supports and maintains cellular shape
and polarity, whilst also enabling cells to migrate. F-actin is
present in cells in part as a microfilament network, which makes
up the cortical actin layer that supports the cell membrane. The
spontaneous formation of actin filaments in high salt conditions
hindered efforts to crystallize actin for structural analysis. High
resolution crystal structures of both G-actin and F-actin were
finally reported in 1990 (Holmes et al., 1990; Kabsch et al., 1990).
The 43kDa G-actin molecule is folded into two similarly sized
domains, separated by a cleft that harbors a binding pocket
for small molecules, for example ATP in vivo or inhibitors
(Kabsch et al., 1990).
F-actin is a dynamic polymer with structural polarity due
to the common orientation of its subunits. It consists of two
twisted helices with an approximate diameter of 5–9 nm (Holmes
et al., 1990). Conventional nomenclature for each filament
end is derived from the appearance of microfilaments during
transmission electron microscopy imaging of samples treated
with myosin S1 fragments (the head and neck domains of non-
muscle myosin II), subsequently fixed with tannic acid (Begg
et al., 1978). Images show myosin-stained actin filaments as
“feather-ended arrows.” The positive (+) end is the “feathered”
barbed end of the “arrow,” for which myosin molecules are the
“feathers” and actin the “arrow” shaft. Conversely, the minus (−)
end is named the pointed end because it is not decorated with
myosin in this context (Figure 1, left inset).
The majority of studies of actin polymerization and
depolymerization have been carried out in vitro rather than
in vivo. In vivo dynamic actin processes are estimated to occur
at least 100 times faster than in vitro (Zigmond, 1993) and are
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likely controlled by the cumulative effects of many different
proteins, meaning that the in vivo processes are hard to study.
The complexity and speed of signals and responses also show
how specific and rapid the modulation of the actin cytoskeleton
can be to different stimuli.
Within cells, both polymerization and depolymerization
require actin binding proteins (Supplementary Table 1 and
Figure 1, right inset). Actin polymerization occurs when G-actin
monomers nucleate to initiate the formation of the F-actin
polymer. This requires nucleating factors, such as Spire or
formins, or the actin-related protein complex (ARP2/3) which
can also act to create branches within filaments (Goley and
Welch, 2006; Dominguez, 2009). Many other proteins alter actin
polymerization and depolymerization kinetics through a variety
of other mechanisms. These include binding actin monomers
and capping, crosslinking and stabilizing actin filaments
(Figure 1, right inset). There are also many actin-binding
proteins responsible for actin depolymerization, although this
remains incompletely understood. Members of the yeast actin
depolymerization factor (ADF)/cofilin family can both enhance
dissociation of monomers from the (−) end (Carlier et al.,
1997) and can sever filaments to create additional (−) ends
(Maciver et al., 1998).
F-actin branching is important in the formation of cellular
protrusions, including cilia, lamellipodia and microvilli, and is
mediated through the action of the actin-related protein complex
(ARP2/3) and Wiskott-Aldrich syndrome proteins (WASp)
(Khaitlina, 2014). ARP2/3 creates branches at 70◦ to the plane of
the original actin filaments which help to establish a supportive
meshwork for membrane protrusions (Mullins et al., 1998).
Branching is an important consideration in disassembly too,
since ADF/cofilin preferentially disassembles branched networks
rather than either parallel or antiparallel filament bundles
(Gressin et al., 2015). Filament severing then occurs at the
boundaries between bare and cofilin-bound filament segments,
so that cofilin binding density regulates overall filament length
(Suarez et al., 2011).
Actin binds and can hydrolyze ATP to ADP (Pollard et al.,
2000). This ability, in part, creates the polarity of the actin
filaments, along with the preferential additional of monomers
to the (+) end of the polymer. Although ATP hydrolysis is
not itself required for polymerization (Cooke, 1975), the critical
concentration of actin required for polymerization to occur is
lower when ATP is bound to G-actin monomers, than when
ADP is bound. ATP is hydrolyzed upon filament assembly and
makes filaments stiffer (Janmey et al., 1990), but this process lags
behind monomer additions, creating a gradient of decreasing
ATP-bound actin towards the (−) end of the filament (Carlier
et al., 1984; Carlier, 1990). The preferential dissociation of ADP-
bound actin results in a “treadmilling” effect, whereby the F-actin
filaments exhibit net growth at their (+) ends and net dissociation
at their (−) ends (Wegner, 1982). The effect of treadmilling
is to create protrusive force in one direction which can be
harnessed by motile cells through the formation of structures
such as lamellipodia, which are transient actin filament-filled
membrane protrusions (Atilgan et al., 2006). Microvilli are
also cellular membrane projections formed by treadmilling
(Lodish et al., 2000). These dynamic equilibria within actin
regulation present another opportunity for modulation by actin
binding proteins. Some proteins act by sequestering ATP-bound
G-actin monomers to negatively affect filament growth, for
example, thymosin beta 4 (Carlier et al., 1993). Others enhance
the nucleotide exchange properties of actin to promote growth,
for example profilin (Goldschmidt-Clermont et al., 1991).
F-actin also forms microfilament bundles which, together
with non-muscle myosin-based motor proteins and actin cross-
linking proteins, form stress fibers. Stress fibers are contractile
bundles of 10–30 actin filaments, crosslinked by alpha-actinin,
found in non-muscle cells with important roles in adhesion,
migration, morphogenesis and mechanotransduction (Tojkander
et al., 2012). Within stress fibers, myosin II protein can slide
along individual actin filaments but non-muscle myosin II
can also form bipolar filaments whereby the myosin II heads
can also attach to different actin filaments, sliding one actin
filament against another to create contractile force (Vicente-
Manzanares et al., 2009). Stress fibers vary greatly in their
morphology and attachment to focal adhesions, and the processes
of their formation and modulation are incompletely understood.
Cytokinetic rings, which form during the final step of cell division
are another example of a contractile, non-muscle, acto-myosin
structure in animal cells (Miller, 2011).
Overall, the highly dynamic and responsive turnover of actin
microfilaments enables the rapid reorganization of the actin
cytoskeleton in response to extracellular and intracellular cues,
particularly for processes dependent on membrane remodeling
such as endocytosis and cytokinesis (Fürthauer and González-
Gaitán, 2009) and the long-range intracellular transport of
vesicles (Schuh, 2011). The large number of proteins that actin
is known to interact with (>150 actin binding proteins) provides
extensive opportunity for localized fine-tuning of the actin
cytoskeleton (Schoenenberger et al., 2011).
ACTIN INHIBITORS AND DETECTION
REAGENTS
Pharmacological perturbation of actin dynamics has been
used to study actin structures within cells. Chemicals that
destabilize or stabilize actin filaments, or that prevent or enhance
polymerization, have been used extensively. However, results
need to be interpreted with caution, since these agents cause
global and extreme alterations of the actin cytoskeleton rather
than the small, localized changes that would be typical in vivo.
The chemicals most often used to destabilize actin
experimentally are a group of fungal metabolites called
cytochalasins. Cytochalasin D is most often used to perturb
actin dynamics because of its favorable inhibition kinetics and
better specificity in comparison to other cytochalasins (Cooper,
1987). Cytochalasin D resembles capping proteins which block
the extension of actin filaments, since it binds the barbed (+)
end of the filament (Cooper, 1987). Cytochalasin D also binds
actin monomers and hydrolyses ATP to decrease the pool of
ATP-bound actin available for polymerization (Goddette and
Frieden, 1986). Treatment of the ciliated hTERT RPE-1 cell-line,
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at low density in growth-promoting medium, with 0.5 µM
cytochalasin D significantly induced ciliogenesis within 8–12 h
(Kim et al., 2010; Nagai and Mizuno, 2017). Cytochalasin D
treatment at 200 nM was also shown to increase cilia length
after only 1 h, in parallel with actin cytoskeleton remodeling that
promoted the directional trafficking of ciliary vesicles towards the
ciliary base (Kim et al., 2015). Additionally, the authors showed
that cytochalasin D treatment resulted in inactivation of the
Hippo pathway transcriptional co-activators YAP (yes-associated
protein) and TAZ (transcriptional coactivator with PDZ-binding
motif, also known as WWTR1) (Kim et al., 2015). These act as
the two primary sensors of a cell’s structure, shape and polarity
(Piccolo et al., 2014) and typically promote cell proliferation
when active (Pan, 2010).
Latrunculin was originally isolated from various marine
sponges and is also used experimentally to depolymerize actin
(Spector et al., 1983). Latrunculin A is the more potent of
the two most common isoforms (A and B) (Spector et al.,
1989). Latrunculin binds actin monomers to prevent them
from polymerizing (Coué et al., 1987; Morton et al., 2000).
Treatment of hTERT RPE-1 cells with 1 µM latrunculin B
significantly induced ciliogenesis within 24 h (Nagai and Mizuno,
2017). Jasplakinolide is another compound originally isolated
from marine sponges that both promotes actin polymerization
and stabilizes filaments (Holzinger, 2010). It is cell membrane
permeable, making it ideal for the treatment of live cells
(Matthews et al., 1997), and treatment of hTERT RPE-1 cells
with 1 µM jasplakinolide significantly induced ciliogenesis
within 12 h (Nagai and Mizuno, 2017). However, jasplakinolide
treatment did not increase in ciliogenesis in cells plated at
higher density (Nagai and Mizuno, 2017), contradicting the
predicted effect of a chemical that promotes actin polymerization
and should therefore suppress ciliogenesis. However, similar
to the effect of the actin destabilizer cytochalasin D (Kim
et al., 2015), jasplakinolide treatment also caused cell rounding,
reduced cell adherence and proliferation, and inactivation of the
transcriptional co-activator YAP (Nagai and Mizuno, 2017). This
reiterates the point that pharmacological perturbation of the actin
cytoskeleton can cause unexpected effects on ciliogenesis, likely
due to the off-target effects of the inhibitor.
Phalloidin is a toxin originally obtained from the death cap
mushroom (Lynen and Wieland, 1938) and is mainly used to
label F-actin but it also acts to stabilize filaments (Wieland, 1977).
Its effectiveness as a toxin, namely its strong specific binding
to F-actin (Kd 0.27 µM), is exactly what has made it a useful
research tool. As previously mentioned, electron microscopy of
actin initially focused on the use of myosin to “decorate” actin
filaments to reveal their polarity (Begg et al., 1978). Antibodies
to actin were created as early as 1979 (Lazarides and Weber,
1974). However, the strong evolutionary conservation of actin
makes it a notoriously weak immunogen and so other detection
methods were sought. Phalloidin binds F-actin with much greater
affinity than G-actin making it ideal to visualize actin structures.
However, binding also stabilizes F-actin up to seven actin
subunits from the binding site (Visegrády et al., 2005), preventing
depolymerization. Stable actin aggregates can form as a result
of phalloidin treatment of live cells (Wehland et al., 1977), so
the stain must be used at very low concentrations to prevent
artifacts. It also preferentially stains the ends of actin structures
and might not stain all F-actin structures in vivo (Visegrády
et al., 2005). Those caveats, plus its slow dissociation rate from
F-actin and the need to microinject it into live cells, mean that
phalloidin is instead most often used to stain fixed preparations
where it remains the gold-standard actin stain (Figures 2A–C).
Despite this, use of phalloidin, either as a directly labeled stain
or as an agent applied to stabilize actin filaments, allowed
the first visualizations of individual actin filaments (Yanagida
et al., 1984; Honda et al., 1986). Observation of individual
actin filaments and their dynamics without the interference
of phalloidin was only possible with the use of alternative
imaging techniques such as total internal reflection fluorescence
microscopy (Fujiwara et al., 2002).
Actin-green fluorescent protein (GFP) fusion proteins have
been used as an alternative to phalloidin in early live-staining
studies of the actin cytoskeleton. However, GFP-tagged actin
monomers polymerize less efficiently than endogenous actin
(Yamada et al., 2005) and have therefore been associated with
altered actin structure and dynamics (Spracklen et al., 2014).
Actin-binding domains fused to GFP have been used to stain
live cells with more success. These have utilized actin binding
domains obtained from moesin in Drosophila melanogaster
(Edwards et al., 1997), utrophin in Xenopus laevis (Burkel
et al., 2007) and Abp120 and LimE in Dictylostelium discoideum
(Pang et al., 1998; Bretschneider et al., 2004). These detection
reagents have large domains and require transfectable cells,
but can also affect F-actin structures and cell mechanics. Most
recently, the much smaller “LifeAct” actin-binding domain,
derived from the initial 17 amino acids of the yeast actin
binding protein 140 (Abp140) (Riedl et al., 2008), has also
been used for the reported ubiquitous visualization of F-actin
(Lemieux et al., 2014; Figure 2B). However, like other proteins
that bind and detect actin, LifeAct has also been reported to
alter actin filament arrangements and dynamics in a dose-
dependent manner (Courtemanche et al., 2016; Flores et al.,
2019) and strong germline in vivo expression in fruit flies
has been shown to cause sterility due to cytoskeletal defects
(Spracklen et al., 2014). F-tractin is another small actin binding
protein fragment, derived from rat inositol triphosphate 3-
kinase (Johnson and Schell, 2009), but is less studied than
LifeAct and also perturbs the actin cytoskeleton in Xenopus
(Belin et al., 2014).
For all of these detection moieties, the fluorescent fusion
protein and even the linker sequence used can alter the subset
of F-actin labeled by the marker (Lemieux et al., 2014). More
recently, chemically synthesized silicon-rhodamine (SiR) based
probes such as SiR-actin have been reported (Lukinavičius
et al., 2014). SiR probes exist in a zwitterion state, of which
the fluorescent “on” state is promoted by interaction with
polar protein surfaces whereas the non-fluorescent “off” state
is promoted by aggregation or binding to hydrophobic surfaces
(Lukinavičius et al., 2013). These probes are cell permeable and
therefore do not require transfection or over-expression, but
there are practical limitations because SiR only emits fluorescence
in far-red and SiR-actin is derived from jasplakinolide so is
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FIGURE 2 | Imaging the actin cytoskeleton and actin-binding proteins within cells. (A) Zeiss Airyscan microscopy images of COS-7 cells probed with an
actin-binding artificial non-antibody binding protein (“Affimer”) biotinylated on the C-terminal cysteine and visualized with fluorescent streptavidin (green). Cells were
co-stained with fluorescent phalloidin (left panel; red) or antibody against non-muscle myosin 2B/MYH10 (right panel; red). Scale bars 10 or 5 µm, as indicated.
(B) Confocal microscopy (upper panel) and high content imaging (lower panel) of ciliated serum-starved mouse inner medullary collecting duct (mIMCD3) cells
expressing LifeAct-GFP (upper panel; green) or probed with AlexaFluor 488-phalloidin conjugate (lower panel; green). Primary cilia are marked by ARL13B (red).
Frame indicates magnified inset showing detail of actin stress fibers in the upper panel. Scale bars = 20 µm. (C) Confocal microscopy image of human female
dermal fibroblasts heterozygous for the FLNA frameshift mutation c.1587delG, p.(K529Nfs*40) (Adams et al., 2012) probed with antibodies for the actin-binding
proteins filamin A (green) and filamin B (red), and counterstained with phalloidin-AlexaFluor633 conjugate (blue). The FLNA gene is carried on the X chromosome and
random X-inactivation in different cells results in either haploinsufficiency (yellow-colored cell; indicated by arrow) or complete loss of filamin A protein
(magenta-colored cell; arrowhead). Scale bar = 10 µm.
likely to perturb actin polymerization and F-actin stabilization
(Melak et al., 2017). Chromobodies have also been used to
visualize actin dynamics in live cells (Rocchetti et al., 2014)
and even whole organisms (Panza et al., 2015). Chromobodies
are nanobodies, the antigen binding domain of single heavy-
chain antibodies found in Camelidae (Hamers-Casterman et al.,
1993), fused to fluorescent proteins such as GFP (Rothbauer
et al., 2006). Chromobodies exhibit highly dynamic binding
which allows the visualization of transient changes in actin
dynamics without impairing actin movement or polymerization
(Rocchetti et al., 2014). The most recent development in
actin visualization are actin-binding artificial non-antibody
binding proteins known as “Affimers” (Lopata et al., 2018;
Figure 2A), although these have been shown to bind less
well to dynamic actin structures. eGFP-Affimers may be more
suitable for specialist applications, for example super-resolution
microscopy or occasions when methanol fixation is required.
Alternatively, they could be used to stain a specific subset
of the cellular actin with further screening to identify more
specific Affimers.
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CILIA AND THE ACTIN CYTOSKELETON
The close associations between cilia and the actin cytoskeleton
are clear from the outset of ciliogenesis, with the requirement
of the actin cytoskeleton for centrosome/basal body migration
and the anchoring of the cilia to the actin cytoskeleton
by focal adhesion complexes (Antoniades et al., 2014). How
these two mechanical constraints could modulate cilia length
throughout ciliogenesis and disassembly (Mirvis et al., 2018)
remains unclear. Since cilia are microtubule-based organelles,
the traditional view has been that they do not contain actin.
However, the curvature of the ciliary membrane clearly requires
a cytoskeleton to maintain organization and an early report
described indirect labeling of actin within the modified cilium
of the photoreceptor using the myosin S1 sub-fragment (Chaitin
and Burnside, 1989). More recently, two different forms of
tagged actin were shown to localize to cilia in a ciliated
cell-line, consistent with a role for F-actin in organizing the
ciliary membrane into discrete sub-compartments known as
nano-domains (Lee et al., 2018). Other reports have also
highlighted the involvement of F-actin in both ciliary decapping
(Phua et al., 2017) and ectosome excision (Nager et al., 2017)
suggesting that actin might play a functional role within cilia,
although it is notable that these studies did not identify
possible actin-severing molecules that could reduce the length
of actin filaments and mediate excision events. Direct detection
of actin in cilia, at molecular resolution, has only recently
been possible by using cryo-electron tomography (cryo-ET)
preparations of primary cilia (Kiesel et al., 2020). This study
identified bundles of actin close to the ciliary membrane
and a structure resembling F-actin that intertwined with
microtubules within the ciliary axoneme (Kiesel et al., 2020).
These localizations were supported by immunofluorescence
microscopy imaging with phalloidin and are consistent with a
functional role of F-actin in maintaining the organization of
the ciliary axoneme (Kiesel et al., 2020). Cryo-ET studies of the
organization and molecular architecture of the primary cilium
remain in their infancy, and there will undoubtedly be many
further insights and surprises as cryo-ET workflows become
integrated with correlated light microscopy studies of individual
ciliary proteins.
F-actin has also been detected as a pool at the base of
the cilium within the ciliary pocket (Molla-Herman et al.,
2010). The ciliary pocket consists of a membrane invagination
that is maintained by stable and dynamic actin filaments,
in which the more dynamic actin is found at the distal
end of the ciliary pocket in order to facilitate directional
ciliary vesicle trafficking of ciliary cargo (Molla-Herman
et al., 2010). This distal region undergoes clathrin-mediated
endocytosis in response to phosphorylated dynein light chain
Tctex-type 1 (DYNLT1) translocating to the transition zone,
prior to S phase entry (Li et al., 2011; Saito et al., 2017).
Phosphorylated DYNLT1 stimulates F-actin polymerization in
the ciliary pocket by binding to actin and recruiting other
regulators of actin polymerization (Saito et al., 2017), which is
proposed to be one of the earliest steps in ciliary disassembly
(Li et al., 2011).
ACTIN AND REGULATION OF
CILIOGENESIS INITIATION AND CILIA
LENGTH
Due to the high volume of traffic into and out of the
cilium during normal cell homeostasis, ciliary maintenance and
stability is essential for its function. The constant renewal of
ciliary membrane proteins and transduction of signal requires
functional IFT and delivery of cargo from the cytoplasm to
the cilium. Currently, the mechanism for the delivery of ciliary
membrane proteins is not fully understood. It is thought that
ciliary cargo is arranged into ciliary-specific vesicles at the trans
Golgi network. These marked vesicles are thought to be trafficked
along the actin cytoskeleton (Kim et al., 2010, 2015; Cao et al.,
2012) rather than microtubules and would therefore move by
association with myosin motors (DePina and Langford, 1999).
The timing of actin dynamics and the exact role in
ciliogenesis still requires further research, as it is poorly
understood. Currently these dynamics are only modeled with
global actin changes, which do not reflect the likely local and
nuanced changes during normal ciliogenesis. In general, actin
depolymerization, through either siRNA knock-down of actin
regulators or pharmacological inhibition of actin polymerization
with cytochalasin D, promotes ciliogenesis in all cell culture
conditions (confluency and presence/absence of serum). Early
studies have shown that pharmacological inhibition of actin
polymerization promoted ciliogenesis and, furthermore, actin
remodeling can transcriptionally control key negative regulators
of ciliary disassembly Aurora A and Plk1 (Kim et al., 2015).
This transcriptional control is mediated though YAP/TAZ-
regulated Hippo signaling, which is activated by the actin
remodeling (see below).
A large “druggable library” siRNA screen, that was published
in 2010, sought to identify modulators of ciliogenesis and cilia
length (Kim et al., 2010). The two main regulators that were
further investigated were gelsolin (GSN), a positive regulator, and
actin-related protein 3 (ACTR3), a negative regulator. Both are
involved in the regulation of actin filament stabilization: GSN
severs actin filaments and ACTR3 inhibits branching. Knock-
downs of these genes, in parallel with cytochalasin D treatment
suggested an important role of branched F-actin in modulating
ciliogenesis, with dynamic or destabilized actin promoting
ciliogenesis and increased cilia length. Cytochalasin D has also
independently been shown to rescue ciliogenesis following siRNA
knock-down of the important ciliary genes CEP290, NPHP5,
and IFT88 (Barbelanne et al., 2013). These studies suggested
that destabilized F-actin increased vesicle trafficking, whereas
stabilized F-actin would create a physical barrier to ciliary vesicle
trafficking around the base of the cilium or centrosome during
ciliogenesis (Kim et al., 2010).
A subsequent study identified LIMK2 and TESK1, two
separate actin regulators exerting effects on cilia incidence (Kim
et al., 2015). Both were linked to increased vesicle trafficking,
which in-turn signaled changes in YAP/TAZ localization and
Hippo signaling (Kim et al., 2015). However, both the screen and
downstream work did not take into account the over-expression
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of Smo, a ciliary marker (Kim et al., 2010). When Smo
is overexpressed it ectopically activates the Shh pathway,
causing excessive GLI activation that is linked to cell cycle
dysregulation (Valente et al., 2010; Kim et al., 2015), thus
potentially confounding the assessment of the ciliary phenotypes
in these studies. Nevertheless, these and previous studies indicate
that actin cytoskeleton remodeling regulate both ciliogenesis
initiation and cilia length.
To gain further mechanistic insight, further studies have
assessed the possible role of non-muscle myosins in the
remodeling of actin during ciliogenesis (Hong et al., 2015).
A study by Rao et al. found that the myosin heavy chains
Myh10 and Myh9 acted antagonistically to modulate ciliogenesis
(Rao et al., 2014). Myh10-dependent actin dynamics were shown
to regulate the correct localization of the pre-ciliary complex
proteins Pcm1 and Cep290, thereby promoting the initiation of
ciliogenesis. Interestingly, loss of cilia following Myh10 knock-
down could be rescued by treatment with blebbistatin, an
inhibitor with broad specificity for non-muscle myosin II that
prevents acto-myosin contraction. These results suggest that
ciliogenesis could be increased through the effects of acto-
myosin contraction on actin cytoskeleton remodeling, leading
to enhanced docking of the basal body at the apical cell surface
during the early stages of ciliogenesis. This may be a separate, but
not mutually exclusive, role to the proposed inhibitory effect of
the actin cytoskeleton on ciliary vesicle transport. However, any
role for ciliary vesicle transport would likely have a rapid and
transient effect on the length of a pre-existing cilium, whereas
acto-myosin contractility would affect basal body docking and
overall cilia incidence over a longer time course of several hours.
These differences in time-course for these potential mechanisms
remain to be formally tested. Conversely, it is also unknown
if actin remodeling can also promote cilia disassembly through
facilitating transport away from the cilium.
ACTIN AT THE CILIARY TIP
In comparison to proximal regions of the cilium, the ciliary tip
has a different composition of proteins, including clathrins and
actin, probably because it is a source of extracellular vesicles
(ECV). The best investigated ECVs are from the retina outer
segment, which allow recycling of opsins through endocytosis
of ECVs by the retinal pigment epithelial cells (Young and
Bok, 1969). In other cell types, ECVs are poorly characterized,
but purified ECVs have been shown to contain ciliary proteins
and transmembrane signaling molecules (Hogan et al., 2009;
Nager et al., 2017). Therefore, ECVs may be used as a type
of ciliary paracrine signaling between cells, or as a way for
the cilium to rapidly regulate the levels of signaling proteins
during signaling responses (Garcia et al., 2018). Recent research
has revealed that disassembly of cilia occurs after an initial
de-capping step generating ciliary ECVs. This de-capping is
controlled by intraciliary F-actin and PI(4,5)P2, to bud off
the tip of the cilium (Phua et al., 2017). Budding has been
suggested to be a mechanism to quickly dispose of ciliary
membrane proteins at the ciliary tip (Nager et al., 2017). This
de-capping step then signals, through an unknown mechanism,
to initiate full ciliary disassembly (Phua et al., 2017) through
Aurora A activation and the direct phosphorylation of histone
deacetylase 6 (HDAC6) (Pugacheva et al., 2007). This in turn
deacetylates the ciliary axoneme, promoting ciliary disassembly.
The full resorption of the remaining cilium is also poorly defined,
and it is unknown if the cilium is resorbed from the base
or is disassembled from the tip down. Further investigation
of the roles of the kinesin-13 family proteins, kinesin family
member 24 (Kif24) and kinesin family member 2A (Kif2a), is
required to elucidate this process. In particular, Kif2a localizes
to the subdistal appendages of the mother centriole, which are
unlikely to play a direct role in depolymerization of axonemal
microtubules (Miyamoto et al., 2015).
ACTIN AND CILIARY STABILITY
In addition to negative modulation of ciliogenesis and cilia
length, actin has also been implicated in maintaining ciliary
stability. Human and mouse mutant models of KDM3A, a
multifunctional protein shown to have roles as a transcription
factor for free actin, have reduced cellular actin levels and an
associated increase in cilia (Yeyati et al., 2017). As there are
decreased levels of actin around the base of the cilium in Kdm3a
mutants, it was proposed that the loss of this physical gate would
allow for an increase in IFT at the cilium, disrupting the balance
of transport proteins (Yeyati et al., 2017). This dysregulation is
further compounded by actin instability causing an increase in
cilia length, further disrupting the balance and regulation of IFT
(Yeyati et al., 2017).
ROLE OF ACTIN IN MOTILE CILIA AND
MULTICILIATED CELLS
Although there is compelling evidence for a functional role for
actin destabilization in promoting ciliogenesis of primary cilia,
in multiciliated cells there is support for the opposite effect
(Pan et al., 2007). Multiciliated cells require basal bodies to both
dock with the cell membrane and to establish polarity so that
the cilia formed may beat in synchrony to establish fluid flow
(Boisvieux-Ulrich et al., 1985; Mitchell et al., 2007). Ciliogenesis
initiates with the formation of centrioles, which in multiciliated
cells form de novo in an acentriolar fashion, i.e., they bud from
an electron dense structure termed the deuterostome instead of
duplicating from a mother centriole (Sorokin, 1968) and are
trafficked to the apical cell surface to form basal bodies. This
trafficking relies on association of the nascent centrioles with
vesicles and the formation of an apical actin network (Boisvieux-
Ulrich et al., 1990). The apical actin network both expands the
membrane surface to allow for the docking of so many basal
bodies, but also spaces them out across the surface of the cell
membrane (Werner et al., 2011; Sedzinski et al., 2016). F-actin
stabilization and an enriched actin web support the docking of
basal bodies in mouse tracheal epithelial cells, thereby promoting
ciliogenesis. This was induced by Forkhead box protein J1
Frontiers in Cell and Developmental Biology | www.frontiersin.org 8 December 2020 | Volume 8 | Article 622822
fcell-08-622822 December 11, 2020 Time: 21:0 # 9
Smith et al. Primary Cilia, Ciliogenesis, Actin Cytoskeleton
(Foxj1), which promoted ras homolog family member A (RhoA)
activity during ciliogenesis (Pan et al., 2007), a process that may
be downstream of initial dynamic actin remodeling that allows
centriole migration. WDR5 has been shown to be important in
both establishing and maintaining the apical F-actin network in
multi-ciliated cells and for the docking and anchoring of basal
bodies at the apical cell membrane (Kulkarni et al., 2018). RhoA,
Fmn1 (Sedzinski et al., 2017), phosphate loop ATPase Nubp1
(Ioannou et al., 2013), ezrin (Huang et al., 2003), Fak (Antoniades
et al., 2014), FoxJ1 (Huang et al., 2003; Stubbs et al., 2008) and
planar cell polarity proteins [including Disheveled (Park et al.,
2008), Inturned and Fuzzy (Park et al., 2006)] have all been shown
to be important in either establishing the apical actin network or




Following on from the seminal large “druggable library” siRNA
screen by Kim et al., which identified a number of actin binding
proteins as modulators of ciliogenesis and cilia length (Kim
et al., 2010), more recent studies have identified additional
actin binding proteins that have novel and unexpected roles in
ciliogenesis and ciliary maintenance. Here we discuss several
actin binding proteins that have been studied in the most detail.
Filamin A
Filamin A (FLNA, previously named FLN1 and ABP-280)
is one of three proteins in the filamin family (Figure 2C).
Filamins anchor the actin cytoskeleton to the cell membrane
by crosslinking actin into networks in the cortical cytoplasm
(Nakamura et al., 2011). They can also bundle actin into stress
fibers (Hirata et al., 2007). FLNA is a ubiquitously expressed,
280 kDa phosphoprotein dimer that consists of three main
domains, an N-terminal actin binding domain that itself contains
two pairs of calponin homology (CH) domains, a rod domain,
consisting of immunoglobulin-like repeats interrupted by two
hinge regions and a C-terminal binding domain important for
both self-dimerization and binding to other membrane receptors
(Wade et al., 2020). Mutations in FLNA cause a variety of
X-linked disorders (Wade et al., 2020). These include multiple
malformation syndromes, congenital short bowel disorder,
terminal osseous dysplasia, cardiac valvular dysplasia and
periventricular heterotopia (Fox et al., 1998; Wade et al., 2020).
Periventricular heterotopia (PH, OMIM #300049) describes the
persistence of nodules of neurons lining the ventricular surface of
the brain following their failure to migrate to the cerebral cortex
(Fox et al., 1998). It results from hypomorphic or loss-of-function
variants that cluster in the actin-binding domain, particularly
within the CH domains (Parrini et al., 2006).
FLNA was first linked to centrosomal trafficking and initiation
of ciliogenesis through the identification of a patient with both
MKS and PH (Adams et al., 2012), who was found to have
a mutation in TMEM67 (c.2754_2756delCTT, p.I918_F919del),
deleting two residues in the C-terminal cytoplasmic region
shown to directly interact with FLNA. FLNA localizes at the
apical cell surface in polarized cells, but also at the basolateral
membrane (Adams et al., 2012), which is also consistent with
the cellular localization of TMEM67 (also known as meckelin)
at both the basal body/transition zone and in non-ciliary vesicles
(Dawe et al., 2007). In vitro and in vivo studies showed
that reduced or absent FLNA caused defects in basal body
positioning and ciliogenesis, and aberrant remodeling of the
actin cytoskeleton. Investigations using fibroblasts from a female
with a heterozygous pathogenic frameshift in FLNA showed
than the basal body positioning was maintained in the mid
portion of the cell rather than at an apical position (Adams
et al., 2012). Similar effects were shown in a null mouse
model and for centrosomal positioning when using siRNA
knockdown on mIMCD3 cells (Adams et al., 2012). Ciliogenesis
was also impaired, but not abolished, in all models. Interestingly,
abrogation of the interaction between TMEM67 and FLNA
resulted in the disruption of RhoA activation and signaling, with
probable downstream effects on non-canonical Wnt signaling
and ciliary function (Adams et al., 2012).
More recently, it has been suggested that transforming acidic
coiled-coil protein 3 (TACC3) may compete with TMEM67
(meckelin) for FLNA binding (Qie et al., 2020). TACC3 is up-
regulated in prostate cancer (Qie et al., 2020) and it promotes
cell growth and differentiation in a number of other cancers
(Lauffart et al., 2005; He et al., 2016; Jiang et al., 2016). Primary
cilia are often reduced or entirely lost in cancerous cells (Schraml
et al., 2009; Gradilone et al., 2013; Menzl et al., 2014), but
knockdown of TACC3 resulted restoration of cilia in a human
prostate cancer cell-line (Qie et al., 2020). It is therefore possible
that over-expression of TACC3 competes with the TMEM67-
FLNA interaction, thereby restricting centrosome migration to
the apical cell surface (Qie et al., 2020).
RhoA
RhoA is the activator of ROCK, a key actin remodeling regulator
that is responsible for the formation of stress fibers (Ridley and
Hall, 1992). RhoA has been shown to contribute to the molecular
pathology of ciliopathies: increased RhoA levels were observed
in dermal fibroblasts from ciliopathy patients with TMEM216
mutations (Valente et al., 2010). Independently, RhoA has also
been shown to mislocalize in patients with JBTS syndrome
(specifically caused by TMEM237 mutations), and patient
fibroblasts had increased actin stress fibers (Huang et al., 2011).
The cellular phenotypes observed in many ciliopathies are
suggested to be due to defects of the actin cytoskeleton
(Valente et al., 2010; Adams et al., 2012; Hernandez-Hernandez
et al., 2013). A study into disease mechanisms of Bardet-
Biedl syndrome observed that Bbs4- and Bbs6-deficient renal
epithelial cells derived from mutant mice had decreased
cilia incidence, associated with increased focal adhesions and
abnormal actin stress fibers. These aberrant changes in the
actin cytoskeleton were ascribed to highly up-regulated RhoA
expression (Hernandez-Hernandez et al., 2013). Since RhoA-
GTP is a direct activator of ROCK, increased ROCK activity
would lead to increased stress fiber formation and F-actin
stabilization. As a consequence, when Bbs4- and Bbs6-deficient
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cells were treated with Y27632, a non-specific inhibitor of the
ROCK and ribosomal S6 kinase (RSK) families, cilia incidence
was rescued. This observation supports the hypothesis that the
actin cellular phenotype is a significant cause of the loss of cilia in
the Bbs4 and Bbs6 mouse mutants, although it does not exclude
the effect of other signaling pathways.
Synaptic Nuclear Envelope Protein 2
Synaptic nuclear envelope protein 2 (SYNE2) is a member
of the nuclear envelope spectrin repeat (nesprin) family of
proteins that comprises four members (Rajgor and Shanahan,
2013). Previously named nesprin-2, SYNE2 is a modular
protein with N-terminal paired calponin homology (CH)
domains, a C-terminal Klarsicht/ANC-1/Syne homology (KASH)
transmembrane domain that acts as a nuclear envelope targeting
motif (Zhen et al., 2002), and a central extended spectrin repeat
rod domain thereby tethering the nucleus to the cytoskeleton.
SYNE2 binds to cytoplasmic F-actin directly through its actin-
binding CH domains, but also itself binds FH1/FH2 domain-
containing protein 1 (FHOD1) and fascins (FSCN1, FSCN2,
FSCN3) which also bind actin (Chang et al., 2015). Collectively,
these contribute to the linker of nucleoskeleton and cytoskeleton
(LINC) complex, which associates the nuclear membranes
with the cytoskeleton, including actin, microtubule filaments,
intermediate filaments, centrosomes and cytoplasmic organelles.
SYNE2 was first linked to centrosome trafficking and early
ciliogenesis, when it was shown that a splice variant lacking
the KASH domain interacts with two MKS proteins (MKS1
and TMEM67) that are required for centrosome migration and
ciliogenesis (Dawe et al., 2009). Depletion of either SYNE1
or SYNE2 caused defective centrosome migration during early
cell polarization, leading to defects in early ciliogenesis (Dawe
et al., 2009). Following depletion or mutation of TMEM67,
SYNE2 localized at actin stress fibers and RhoA signaling
aberrantly increased, implicating SYNE2 in the control of the
actin cytoskeleton during cell polarization and early ciliogenesis
(Dawe et al., 2009). Subsequent work in a ciliated cell-line with a
gene-edited SYNE2 knockout has supported a functional role for
SYNE2 during ciliogenesis (Falk et al., 2018).
SYNE2 has also been shown to interact with pericentrin
(PCNT) (Falk et al., 2018). PCNT is a component of
pericentriolar material (present at the base of cilia) and is a large
coiled coil protein which localizes to the centrosome via a PACT
motif (Miyoshi et al., 2006). It also serves as a protein scaffold
and contributes to mitotic spindle organization and ciliogenesis
(Jurczyk et al., 2004; Zimmerman et al., 2004). SYNE2 and
PCNT have been shown to co-localize at the connecting cilium
of the photoreceptor cells of the retina (Mühlhans et al., 2011;
Falk et al., 2018). Gene-edited SYNE2 cells, lacking the PCNT
binding domain, also had shorter cilia compared to other mutant
SYNE2 cells with the domain, suggesting that the interaction may
be required for delivery of ciliary proteins to the ciliary base
(Falk et al., 2018).
PCARE and Retinal Outer Segments
An example of the importance of the actin cytoskeleton in the
role of cilia within specialized cell types has been highlighted in
a recent paper on photoreceptors (Corral-Serrano et al., 2020).
The connecting cilium between the inner and outer segments of
photoreceptors is analogous to a typical ciliary transition zone,
with the outer segment effectively acting as a modified primary
cilium. Within every photoreceptor outer segment, around 10%
of the light-sensing, opsin-containing discs are shed daily at the
apical end (Young, 1967). New discs form at the base and move
through the length of the outer segment until their shedding and
destruction. The mechanism by which new discs are formed has
been shown to involve expansion of the ciliary plasma membrane
at the point at which the connecting cilium meets the base
of the outer segment, but the proteins involved in driving the
expansions have only recently been identified.
Photoreceptor cilium actin regulator (PCARE, previously
named C2orf71; Figure 3) was first identified when it was shown
to be mutated in a subset of retinitis pigmentosa patients (RP54)
(Collin et al., 2010; Nishimura et al., 2010). Its expression is
predominantly retinal and it contains a W2 domain thought to
bind to actin filaments (Corral-Serrano et al., 2020). Through
interaction studies, PCARE has been shown to interact with
retinal disease proteins associated with the centrioles of the
centrosome and basal body as well as actin proteins associated
with de novo F-actin network assembly including ARP2/3,
ENAH, gelsolin, profilin 1, profilin 2, MYL12A, MYL12B,
LIMA1, filamin A and WASF3 (Corral-Serrano et al., 2020).
PCARE in mice localizes to the basal body, the microtubules
of the connecting cilium and extends into the newer outer
segment discs (Figure 3) and Pcare−/− mice have disrupted OS
disc stacking (Corral-Serrano et al., 2020). Overexpression of
PCARE in hTERT RPE-1 cells resulted in WASF-3 translocating
from F-actin to the cilium and induced expansion of the ciliary
membrane to form a bulbous tip (Corral-Serrano et al., 2020).
Culture of retinal organoids showed that such expansions formed
the new outer segment discs. Inhibition of actin polymerization
by cytochalasin D or lantrunculin B treatment also reduced the
formation of the ciliary tip expansions, as did siRNA knockdown
of ARP2 in mIMCD3 cells (Corral-Serrano et al., 2020). Similarly,
RP-causing mutant PCARE had the same localization as wild-
type protein but failed to cause the same expansion of the ciliary
tip, interpreted as a failure to induce actin remodeling (Corral-
Serrano et al., 2020). It therefore appears that PCARE is a retinal
specialist protein that facilitates actin remodeling via recruitment
of WASF3 to induce membrane expansion that produces new
outer segment discs for photo-sensing.
Leucine Zipper Protein 1
Another important actin binding protein implicated in
ciliogenesis is leucine zipper protein 1 (LUZP1) (Wang and
Nakamura, 2019). In cycling cells, LUZP1 localizes to the
pericentriolar matrix at the proximal end of each centriole, the
actin cytoskeleton and the midbody (Bozal-Basterra et al., 2020).
In cell cycle-arrested cells, LUZP1 localizes to the basal body
and to the ciliary axoneme. LUZP1 has been shown to bind
directly with actin but also through interactions with filamin
A (Hein et al., 2015; Wang and Nakamura, 2019) and ARP2
(Hein et al., 2015). A functional role for LUZP1 in ciliogenesis
has been suggested through studies of the molecular etiology
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FIGURE 3 | Ciliary membrane remodeling of the actin-binding protein PCARE in the primary cilium and photoreceptor connecting cilium. The proposed role of
PCARE in the cilium (left panel) and in the specialized cilium of the photoreceptor outer segment and connecting cilium (right panel) are indicated. PCARE (red)
has been shown to interact with actin-binding proteins (dark red symbols) associated with de novo F-actin network assembly including the ARP2/3 complex,
gelsolin, profilin and WASF3 (orange). PCARE in mice localizes to the basal body, the microtubules of the connecting cilium and extends into the newer outer
segment discs (Corral-Serrano et al., 2020). Overexpression of PCARE in hTERT RPE-1 cells resulted in WASF-3 translocating from F-actin to the cilium and induced
expansion of the ciliary membrane to form a bulbous tip (left panel). PCARE is a retinal specialist protein that facilitates actin remodeling via recruitment of WASF3
to induce membrane remodeling and expansion that produces new outer segment discs for photo-sensation in the photoreceptor cell (Corral-Serrano et al., 2020).
of Townes-Brocks syndrome (TBS1 MIM #107480). In TBS1
cells, cilia are longer and occur at a higher incidence than in
wildtype cells. TBS1 is caused by mutations in the spalt-like
transcription factor 1 gene (SALL1) (Kohlhase et al., 1998).
The encoded protein, SALL1, normally interacts with and
removes negative regulators of ciliogenesis (CCP110 and CEP97)
from the mother centriole, thereby promoting ciliogenesis.
However, truncated mutant forms of SALL1 that cause TBS1
appear to interact with LUZP1 (Bozal-Basterra et al., 2018). This
interaction causes LUZP1 degradation through the ubiquitin
proteasome system, since inhibition of the proteasome in TBS1
cells lead to accumulation of LUZP1 (Bozal-Basterra et al.,
2020). Loss of LUZP1 results in reduced actin polymerization,
increased cilia incidence and length, and increased Shh signaling
(Bozal-Basterra et al., 2020; Gonçalves et al., 2020). In contrast,
over-expression of LUZP1 in TBS1 cells resulted in increased
levels of F-actin and reduced ciliogenesis to normal levels,
suggesting that LUZP1 is a potential therapeutic target for the
treatment of TBS1 (Bozal-Basterra et al., 2020).
PROXIMITY LABELING STUDIES
Studies utilizing proximity labeling to identify ciliary proteins
have reported varied results for detection of actin binding
proteins (Mick et al., 2015; Kohli et al., 2017). One study revealed
a surprising number of actin binding proteins within cilia (Kohli
et al., 2017). Kohli et al. used enzyme-catalyzed proximity labeling
with an engineered ascorbate peroxidase (APEX2) that was
specifically targeted to the ciliary membrane (Kohli et al., 2017).
Actin-binding proteins that were identified in close proximity to
the ciliary membrane included activins, tropomyosins, coronin,
ezrin, gelsolin, cortactin, utrophin, drebrin-like protein, and,
most abundantly, alpha-activin and filamin A (Kohli et al., 2017).
However, it was unclear if proximity labeling was also tagging
actin-binding proteins during trafficking of the construct at the
ciliary pocket which would argue against a specific role for these
proteins within cilia. Paradoxically, levels of these actin binding
proteins increased in the ciliary compartment after cells were
treated with the actin-depolymerizing agent cytochalasin D (see
above). An earlier study, utilizing APEX that was specifically
targeted to the ciliary lumen using nephrocystin 3, failed to detect
actin binding proteins within the cilium (Mick et al., 2015).
Actin depolymerization may therefore trigger the recruitment
of actin-binding proteins to the cilium (Kohli et al., 2017), but it
remains unclear how this leads to axonemal extension and cilium
elongation, and whether actin-binding proteins have a direct role
in this process. It is possible that actin de-polymerization causes
the non-specific release of the pool of proteins normally bound to




Interest in modification of the actin cytoskeleton as a possible
treatment for ciliopathies grew from the finding that positive
regulators of actin polymerization exerted negative effects on
ciliogenesis and vice versa (Kim et al., 2010). Kim et al. (2010)
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also found that cytochalasin D treatment, which prevents actin
polymerization, significantly rescued the ciliogenesis defect in
hypomorphic IFT88 mutant cells (Ift88orpk/orpk). Cytochalasin
D is unsuitable for treatment of ciliopathies in whole organisms
because of the effects of global inhibition of actin polymerization,
that include failure of cytokinesis, aneuploidy, cell cycle arrest
and apoptosis, as well as off-target effects of the inhibitor.
However, other inhibitors that target actin modulators implicated
in ciliogenesis have been suggested to be more suitable for
pharmacological intervention and treatment (Kim et al., 2010).
Drugs that act on actin binding proteins and increase cilia
incidence could also be valuable for diseases of spontaneous
epithelial-mesenchymal transition and uncontrolled cell division
such as cancer (Izdebska et al., 2018). Specific molecules targeting
some actin binding proteins have been designed, specifically
against ARP2/3 (Nolen et al., 2009), non-muscle myosin II
(MYH9/10) (Saitoh et al., 1987; Straight et al., 2003) and
neuronal WASP (Peterson et al., 2004). However, to date,
undesirable effects of such general inhibition have precluded
these compounds from clinical practice (Chánez-Paredes et al.,
2019). Tissue-specific inhibition through the specific targeting of
an actin binding protein such as a PCARE or a SYNE2 isoform
expressed only in brain and kidney could be a more specific
therapeutic strategy to modulate actin conditions in tissues that
express ciliopathy phenotypes.
IDENTIFICATION OF THERAPEUTICS
FOR CYSTIC KIDNEY DISEASE
Several drugs screens have been completed to identify
compounds that could be used to modulate the actin cytoskeleton
and increase ciliogenesis (Table 1). These screens have focused
on the kidney since polycystic kidney disease is relatively
common [4 in 10,000 in Europe (Willey et al., 2017)] and cystic
kidney disease is a common feature of many ciliopathies (Habbig
and Liebau, 2015). Practically, kidney disease presents later
than many other symptoms of ciliopathies, such as retinitis
pigmentosa or developmental brain anomalies and therefore
there is a therapeutic window ex utero where a drug could be
given. In addition, cell lines of kidney origin (e.g., mIMCD3)
are used as a standard model in cilia research and can be easily
assayed using high-throughput microscopy (Wheway et al.,
2015). Patient cells can also be isolated through collection and
culture of urinary renal epithelial cells (URECs) from urine or
through collection of kidney cysts for more focused screening
of hit compounds (Loghman-Adham et al., 2003; Ajzeberg
et al., 2015). Future screens are likely to test compounds on
kidney organoids due to advances in gene editing and directed
differentiation of induced pluripotent stem cells (iPSCs).
IPSCs can be engineered to carry specific mutations of interest
using CRISPR-Cas9 editing and kidney organoids can be
produced from iPSCs in less than a month of differentiation
(Takasato and Little, 2017).
Of the tens of drugs screens carried out, one screen of 1600
compounds identified 118 hits that restored cilia expression in
the CFPAC-1 pancreatic cancer cell line (Khan et al., 2016). The
authors stated that many of these compounds affected levels of
cAMP, calcium or other ions and highlighted glucocorticoids
as the main drug class identified. Notably, glucocorticoids can
both stimulate and inhibit Smo accumulation in cilia during
Sonic Hedgehog signaling (Wang et al., 2012). Other hits
identified included neurotransmitter regulators and ion channel
modulators, as well as compounds that were previously identified
to increase cilia incidence, cilium length or ciliary beat frequency
in multi-ciliated cells.
Several other small molecule screens have highlighted
inhibition of ROCK, amongst many other pathways, as a
potential therapeutic for cystic kidney disease. One study
screened 273 kinase inhibitors in a forskolin-stimulated 3D cyst
assay using an IMCD3 cell line expressing a short hairpin RNA
targeting polycystin 1 transcripts and identified thiazovivin (a
non-selective ROCK inhibitor) as a significant hit (Booij et al.,
2017). Hits also included inhibitors of IGF-1R, HER2, CHK1/2,
PLK1, CDKs and AURKA but the largest category was for
inhibitors of mTOR (Booij et al., 2017). The identification of
inhibitor hits for so many different pathways may reflect the
importance of proliferation in cyst growth and highlights that the
use of these inhibitors is unlikely to be a useful treatment, due
to off-target effects with other kinases and the effects of global
inhibition of these pathways on the organism as a whole.
One recent screen assessed the effects of 8,814 compounds,
mostly with proven anti-neoplastic effects, on autosomal
dominant polycystic kidney disease type 1 (ADPKD1) adult and
fetal cell models (Asawa et al., 2020). This screen looked for
compounds that reduced cell viability of polycystin 1 (PKD1)
null lines but not of wildtype cells. The authors then rescreened
a selection of compounds for their effects on a 3D cyst culture
(unstimulated by cAMP). Although some compounds had no
effect on cell viability in 2D, they had significant effects on
cyst growth in the 3D model (Asawa et al., 2020). Compounds
that affect cell viability or proliferation are unlikely to be
effective treatments for all stages of renal cystic disease. However,
a number of compounds had no effect on cell viability but
nevertheless still reduced cyst size. These included several
compounds known to affect microtubule dynamics, including a
DNMT1 inhibitor, an M1 aminopeptidase inhibitor and a ROCK
inhibitor (GSK 269962). These are promising compounds for
future studies of clinical efficacy and potential repurposing.
In support of the potential repurposing of known ROCK
inhibitors, one study demonstrated rescue of cord and tubule
formation whilst reducing cyst formation in the cystogenic Pkd1
knock-out 3D kidney cell-line model (Cai et al., 2018). This
study identified that Pkd1 knock-out caused an increase in
RhoA-ROCK-MLC signaling, leading to downstream activation
of the Hippo signaling pathway. Screening of a panel of 155
kinase inhibitors identified five hit compounds, of which all were
ROCK inhibitors, including a selective ROCK2 inhibitor, which
suggests that pharmacological targeting of ROCK2 rather than
ROCK1 may have therapeutic benefit. Further investigation of
the efficacy of these drugs using more physiologically relevant,
slower developing models of cystic kidney disease, is warranted.
It is also important to test the drugs using models that had already
developed cysts rather than treating models prophylactically,






















TABLE 1 | Drug screens to identify compounds that modulate the actin cytoskeleton and increase ciliogenesis.
Cell line/origin Mutational
model
Cell culture Stimulation Drug library Methodology Output (assay
markers)
Validation Hit categories Specific Hits References
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CFPAC-1, ductal pancreatic adenocarcinoma cell-line; mIMCD3, murine inner medullary collecting duct kidney epithelial cell-line; MEK, murine embryonic kidney cells derived from collecting duct and post-natal
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before cysts had appeared, to see whether ROCK inhibitors can
ameliorate existing disease.
Aside from screens, ROCK inhibitors have also been shown
to restore cilia in a Rho GTPase activating protein (GAP)
mutant mouse model (Arhgap35D34/D34) that had reduced cilia
incidence and length (Stewart et al., 2016). This Rho-GAP
mutant had increased RhoA activation as a result of reduced
intrinsic hydrolytic activity due to inactivation of ARHGAP35.
The mutant mouse model also displayed a glomerulocystic
kidney phenotype, thus linking RhoA hyperactivity and failures
in ciliogenesis to cystogenesis (Stewart et al., 2016). Further
investigation identified a reduction in cilia within the proximal
tubule during development, resulting from a failure in axoneme
elongation rather than basal body migration or docking (Stewart
et al., 2016). The authors concluded that local negative regulation
of Rho-GAPs is required at the ciliary base to enable axoneme
extension (Stewart et al., 2016). A more recent study reported
that dysregulation of RhoA signaling at the centrosome, mediated
by ARHGAP35, led to increased activation of ROCKs in mutant
or null PKD1 cells (Streets et al., 2020). The authors found that
treatment of PKD1 patient cells and an inducible, kidney specific
Pkd−/− mouse model with the ROCK inhibitor hydroxyfasudil
reduced cyst size over 7 days of treatment (Streets et al.,
2020). Collectively, these findings call for the assessment of
the effects of different ROCK inhibitors on cyst growth and
development in human cell and animal models. Assessment of
the relative contributions of F-actin stabilization and acto-myosin
contraction to ciliogenesis and cilia maintenance over different
time periods will be key to understanding how ROCK inhibitors
modulate cilia. Parallel investigations should also assess the effect
on ROCK inhibition on ciliary-mediated signaling functions.
CONCLUSION AND FUTURE
DIRECTIONS
It is now recognized that the centrosome acts as both a
microtubule and actin organizing center, and therefore that the
actin cytoskeleton and ciliogenesis are intrinsically linked. It is
also clear that the actin cytoskeleton exerts multiple effects on
ciliogenesis, cilia maintenance, signaling and function, making
it an important potential drug target. The large number of
actin-binding proteins that are involved in actin dynamics,
often in cell-specific processes, means that targeting can be
potentially fine-tuned depending upon the cell type. Greater
understanding of actin remodeling will come from improved
actin detection and visualization of highly dynamic remodeling
events, including the use of super-resolution microscopy and
the use of proximity labeling studies to identify novel actin
binding proteins.
In the next stages of this research, additional screens of
candidate drugs or small molecules should be completed, using a
number of different models of cystic kidney disease, with different
genetic aberrations and backgrounds and with treatment at
different disease stages. These studies will be required to discern
whether inhibitors of ROCK or other targets that modulate the
actin cytoskeleton may have potential clinical efficacy in the
treatment of cystic kidney diseases. These screens will also help
to determine the points at which disease can be ameliorated and
which disease stage would be most amenable to the effects of
each drug. RNA expression profiling of ADPKD and Pkd1−/−
kidney cysts compared with healthy kidney tissue supports the
targeting of the RhoA-YAP-cMyc axis (Cai et al., 2018), but
wider profiling could be useful to identify other pathways to
target at specific timepoints in cystogenesis or for particular
genotypes. Additional profiling could also be useful to narrow
the pathways already identified, which include regulation of
calcium ions, cAMP, MAPK, JAK, SRC, STAT, Wnt, and mTOR
(Lemos and Ehrlich, 2018). It will be interesting to determine if
activation of the RhoA-YAP-cMyc signaling axis is also observed
in cysts from other disease models with mutations in other
genes. However, the renal sub-location where cysts develop is
partially dependent on genotype (Gascue et al., 2011), and it
is therefore likely that pathomechanisms will depend on the
genetic etiology of the cystic kidney disease. Different disease
types may therefore require different drug therapies, although
the therapeutic targeting of a single actin modulator such as
ROCK may provide a common strategy that is suitable for several
disease classes. It is notable that several newly developed ROCK
inhibitors are experimental drugs currently (October 2020) in
phase II clinical trials for treatment of chronic graft-versus-host
disease, idiopathic pulmonary fibrosis and psoriasis. It will be
interesting to determine if these drugs could be re-purposing for
treatment of cystic kidney disease.
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Fox, J. W., Lamperti, E. D., Ekşioğlu, Y. Z., Hong, S. E., Feng, Y., Graham, D. A.,
et al. (1998). Mutations in filamin 1 prevent migration of cerebral cortical
neurons in human periventricular heterotopia. Neuron 21, 1315–1325. doi:
10.1016/s0896-6273(00)80651-0
Francis, S. S., Sfakianos, J., Lo, B., and Mellman, I. (2011). A hierarchy of signals
regulates entry of membrane proteins into the ciliary membrane domain in
epithelial cells. J. Cell Biol. 193, 219–233. doi: 10.1083/jcb.201009001
Fujiwara, I., Takahashi, S., Tadakuma, H., Funatsu, T., and Ishiwata, S. (2002).
Microscopic analysis of polymerization dynamics with individual actin
filaments. Nat. Cell Biol. 4, 666–673. doi: 10.1038/ncb841
Fürthauer, M., and González-Gaitán, M. (2009). Endocytosis and mitosis: a two-
way relationship. Cell Cycle 8, 3311–3318. doi: 10.4161/cc.8.20.9700
Gansevoort, R. T., Arici, M., Benzing, T., Birn, H., Capasso, G., Covic, A., et al.
(2016). Recommendations for the use of tolvaptan in autosomal dominant
polycystic kidney disease: a position statement on behalf of the ERA-EDTA
working groups on inherited kidney disorders and european renal best practice.
Nephrol. Dial. Transplant. 31, 337–348. doi: 10.1093/ndt/gfv456
Garcia, G. III, Raleigh, D. R., and Reiter, J. F. (2018). How the ciliary membrane
is organized inside-out to communicate outside-in. Curr. Biol. 28, R421–R434.
doi: 10.1016/j.cub.2018.03.010
Gascue, C., Katsanis, N., and Badano, J. L. (2011). Cystic diseases of the kidney:
ciliary dysfunction and cystogenic mechanisms. Pediatr. Nephrol. 26, 1181–
1195. doi: 10.1007/s00467-010-1697-5
Gattone, V. H. II, Wang, X., Harris, P. C., and Torres, V. E. (2003). Inhibition of
renal cystic disease development and progression by a vasopressin V2 receptor
antagonist. Nat. Med. 9, 1323–1326. doi: 10.1038/nm935
Goddette, D. W., and Frieden, C. (1986). Actin polymerization. The mechanism of
action of cytochalasin D. J. Biol. Chem. 261, 15974–15980.
Goldschmidt-Clermont, P. J., Machesky, L. M., Doberstein, S. K., and Pollard, T. D.
(1991). Mechanism of the interaction of human platelet profilin with actin.
J. Cell Biol. 113, 1081–1089. doi: 10.1083/jcb.113.5.1081
Goley, E. D., and Welch, M. D. (2006). The ARP2/3 complex: an actin
nucleator comes of age. Nat. Rev. Mol. Cell Biol. 7, 713–726. doi: 10.1038/nrm
2026
Gonçalves, J., Sharma, A., Coyaud, É, Laurent, E. M. N., Raught, B., and Pelletier,
L. (2020). LUZP1 and the tumor suppressor EPLIN modulate actin stability to
restrict primary cilia formation. J. Cell Biol. 219:e201908132. doi: 10.1083/jcb.
201908132
Gradilone, S. A., Radtke, B. N., Bogert, P. S., Huang, B. Q., Gajdos, G. B.,
and LaRusso, N. F. (2013). HDAC6 inhibition restores ciliary expression and
decreases tumor growth. Cancer Res. 73, 2259–2270. doi: 10.1158/0008-5472.
Can-12-2938
Gressin, L., Guillotin, A., Guérin, C., Blanchoin, L., and Michelot, A. (2015).
Architecture dependence of actin filament network disassembly. Curr. Biol. 25,
1437–1447. doi: 10.1016/j.cub.2015.04.011
Habbig, S., and Liebau, M. C. (2015). Ciliopathies – from rare inherited cystic
kidney diseases to basic cellular function. Mol. Cell Pediatr. 2:8. doi: 10.1186/
s40348-015-0019-1
Halliburton, W. D. (1887). On muscle-plasma. J. Physiol. 8, 133–202. doi: 10.1113/
jphysiol.1887.sp000252
Hamers-Casterman, C., Atarhouch, T., Muyldermans, S., Robinson, G., Hamers,
C., Songa, E. B., et al. (1993). Naturally occurring antibodies devoid of light
chains. Nature 363, 446–448. doi: 10.1038/363446a0
Hatano, S., and Oosawa, F. (1966). Isolation and characterization of plasmodium
actin. Biochim. Biophys. Acta. 127, 488–498. doi: 10.1016/0304-4165(66)
90402-8
He, J. C., Yao, W., Wang, J. M., Schemmer, P., Yang, Y., Liu, Y., et al. (2016). TACC3
overexpression in cholangiocarcinoma correlates with poor prognosis and is a
potential anti-cancer molecular drug target for HDAC inhibitors. Oncotarget 7,
75441–75456. doi: 10.18632/oncotarget.12254
Hein, M. Y., Hubner, N. C., Poser, I., Cox, J., Nagaraj, N., Toyoda, Y., et al.
(2015). A human interactome in three quantitative dimensions organized by
stoichiometries and abundances. Cell 163, 712–723. doi: 10.1016/j.cell.2015.
09.053
Hernandez-Hernandez, V., Pravincumar, P., Diaz-Font, A., May-Simera, H.,
Jenkins, D., Knight, M., et al. (2013). Bardet-Biedl syndrome proteins control
the cilia length through regulation of actin polymerization. Hum. Mol. Genet.
22, 3858–3868. doi: 10.1093/hmg/ddt241
Hirata, H., Tatsumi, H., and Sokabe, M. (2007). Dynamics of actin filaments during
tension-dependent formation of actin bundles. Biochim. Biophys. Acta. 1770,
1115–1127. doi: 10.1016/j.bbagen.2007.03.010
Hogan, M. C., Manganelli, L., Woollard, J. R., Masyuk, A. I., Masyuk, T. V.,
Tammachote, R., et al. (2009). Characterization of PKD protein-positive
exosome-like vesicles. J. Am. Soc. Nephrol. 20, 278–288. doi: 10.1681/ASN.
2008060564
Holmes, K. C., Popp, D., Gebhard, W., and Kabsch, W. (1990). Atomic model of
the actin filament. Nature 347, 44–49. doi: 10.1038/347044a0
Holzinger, A. (2010). “Jasplakinolide: an actin-specific reagent that promotes actin
polymerization,” in Cytoskeleton Methods and Protocols, 2 Edn, ed. R. H. Gavin
(Totowa, NJ: Humana Press), 71–87. doi: 10.1007/978-1-60761-376-3_4
Honda, H., Nagashima, H., and Asakura, S. (1986). Directional movement of
F-actin in vitro. J. Mol. Biol. 191, 131–133. doi: 10.1016/0022-2836(86)90428-6
Hong, H., Kim, J., and Kim, J. (2015). Myosin heavy chain 10 (MYH10) is required
for centriole migration during the biogenesis of primary cilia. Biochem. Biophys.
Res. Commun. 461, 180–185. doi: 10.1016/j.bbrc.2015.04.028
Huang, L., Szymanska, K., Jensen, V. L., Janecke, A. R., Innes, A. M., Davis, E. E.,
et al. (2011). TMEM237 is mutated in individuals with a Joubert syndrome
related disorder and expands the role of the TMEM family at the ciliary
transition zone. Am. J. Hum. Genet. 89, 713–730. doi: 10.1016/j.ajhg.2011.
11.005
Huang, T., You, Y., Spoor, M. S., Richer, E. J., Kudva, V. V., Paige, R. C., et al. (2003).
Foxj1 is required for apical localization of ezrin in airway epithelial cells. J. Cell
Sci. 116, 4935–4945. doi: 10.1242/jcs.00830
Huangfu, D., Liu, A., Rakeman, A. S., Murcia, N. S., Niswander, L., and Anderson,
K. V. (2003). Hedgehog signalling in the mouse requires intraflagellar transport
proteins. Nature 426, 83–87. doi: 10.1038/nature02061
Husson, H., Moreno, S., Smith, L. A., Smith, M. M., Russo, R. J., Pitstick, R., et al.
(2016). Reduction of ciliary length through pharmacologic or genetic inhibition
of CDK5 attenuates polycystic kidney disease in a model of nephronophthisis.
Hum. Mol. Genet. 25, 2245–2255. doi: 10.1093/hmg/ddw093
Ioannou, A., Santama, N., and Skourides, P. A. (2013). Xenopus laevis nucleotide
binding protein 1 (xNubp1) is important for convergent extension movements
and controls ciliogenesis via regulation of the actin cytoskeleton. Dev. Biol. 380,
243–258. doi: 10.1016/j.ydbio.2013.05.004
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